Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
- DOI
- 10.1016/s0140-6736(14)62225-x
- Published
- 2015 May 23
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-14-62225-x,
title = {Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.},
author = {Zannad F and Cannon CP and Cushman WC and Bakris GL and Menon V and Perez AT and Fleck PR and Mehta CR and Kupfer S and Wilson C and Lam H and White WB and EXAMINE Investigators},
year = {2015},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(14)62225-x},
url = {https://doi.org/10.1016/s0140-6736(14)62225-x}
}RIS
TY - JOUR TI - Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. AU - Zannad F AU - Cannon CP AU - Cushman WC AU - Bakris GL AU - Menon V AU - Perez AT AU - Fleck PR AU - Mehta CR AU - Kupfer S AU - Wilson C AU - Lam H AU - White WB AU - EXAMINE Investigators PY - 2015 JO - Lancet (London, England) DO - 10.1016/s0140-6736(14)62225-x UR - https://doi.org/10.1016/s0140-6736(14)62225-x ER -
APA
F, Z., CP, C., WC, C., GL, B., V, M., AT, P., PR, F., CR, M., S, K., C, W., H, L., WB, W., & Investigators, E. (2015). Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(14)62225-x
Source records
- pubmed · retrieved 2026-09-26T08:18:32.970Z